comparemela.com

Latest Breaking News On - Repros therapeutics - Page 1 : comparemela.com

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Terry-coyne
Chris-schott
Geoff-meacham
Terrance-coyne
Chris-shibutani
Marshall-urist
Pablo-legorreta
George-grofik
Repros-therapeutics-inc
Goldman-sachs

Royalty Pharma plc (NASDAQ:RPRX) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter 2023 Earnings Conference Call.

Chris-schott
Stephen-scala
George-grofik
Christopher-schott
Andrew-baum
Marshall-urist
Pablo-legorreta
Terrance-coyne
Terry-coyne
Repros-therapeutics-inc
Nasdaq
Life-sciences

Royalty Pharma plc (NASDAQ:RPRX) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma First Quarter Earnings Conference Call.

Chris-shibutani
Chris-schott
Astrazeneca-airsupra
Pablo-legorreta
Karuna-kar
Marshall-urist
George-grofik
Terry-coyne
Health-photo
Repros-therapeutics-inc
Life-sciences
Goldman-sachs

With earning season winding down, investors await meeting on debt limit

The high-stakes game of chicken being played in Washington has investors on edge. 

New-york
United-states
White-house
District-of-columbia
Washington
Hawaii
Brookfield
American
Hawaiian
Kevin-mccarthy
Henry-schein
Estee-lauder

Royalty Pharma plc (NASDAQ:RPRX) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Fourth Quarter Earnings Conference Call. Please be advised that today s conference is being recorded.

Terry-coyne
Pablo-legorreta
Chris-schott
Astrazeneca-airsupra
George-grofik
Marshall-urist
Chris-shibutani
Repros-therapeutics-inc
Amgen
Head-of-research
Goldman-sachs

vimarsana © 2020. All Rights Reserved.